Patient Spotlight: Anthony Anzell Fights Hereditary Hemorrhagic Telangiectasia with Endurance and Education Dakota Campbell Tue, 10/19/2021 - 14:05
Headshot of Anthony Anzell, PhD
Anthony Anzell, PhD

Anthony Anzell, PhD, is a postdoctoral fellow at the University of Pittsburgh studying hereditary hemorrhagic telangiectasia (HHT). He also happens to be an HHT patient. Here, Dr. Anzell shares his HHT journey, from diagnosis, to ultramarathons, to the lab. 

Spotlight on RDCRN Consortia: Vasculitis Clinical Research Consortium Anonymous (not verified) Fri, 01/06/2012 - 10:53

The Vasculitis Clinical Research Consortium (VCRC) is an international, multi-center, clinical research infrastructure for the study of vasculitis.